Destruction Of Cancer Skin Growth Of Trunk, Arms, Or Legs, 2.1-3.0 Cm in Pennsylvania
Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in Pennsylvania
| Provider | Medicare | Services |
|---|---|---|
| Neustadter, Jason M.D. | $145.37 | 81 |
| Bronfenbrener, Roman MD | $140.51 | 80 |
| Roling, Daniel M.D. | $145.18 | 77 |
| Thieu, Khanh M.D. | $145.99 | 69 |
| Pfingstler, Lisa M.D. | $125.13 | 59 |
| Hendrix, Jason D.O. | $132.57 | 58 |
| Stoner, John D.O. | $133.92 | 45 |
| Thieu, Minh M.D. | $143.84 | 39 |
| Fulchiero, Gregory M.D., M.S. | $120.82 | 31 |
| Meskey, Thomas M.D. | $131.51 | 30 |
Pennsylvania Pricing in Context
In Pennsylvania, CPT code 17263 (Destruction Of Cancer Skin Growth Of Trunk, Arms, Or Legs, 2.1-3.0 Cm) carries an average Medicare payment of $129.59 — 0% above the national benchmark of $129.39. 449 providers across the state submitted claims for this procedure in 2023, performing 2.5K total services. Individual payments in PA ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in Pennsylvania is $365.76, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Pennsylvania sits above the national Medicare average, commercial rates in the state may also run higher than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Skin/Integumentary Surgery procedures, the estimated commercial insurance price in Pennsylvania lands near $375.19, with self-pay cash prices typically around $228.49. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Destruction Of Cancer Skin Growth Of Trunk, Arms, Or Legs, 2.1-3.0 Cm cost in Pennsylvania?
The average Medicare payment for Destruction Of Cancer Skin Growth Of Trunk, Arms, Or Legs, 2.1-3.0 Cm in Pennsylvania is $129.59, which is 0% above the national average of $129.39. Providers in PA typically bill $365.76 for this procedure.
What does Destruction Of Cancer Skin Growth Of Trunk, Arms, Or Legs, 2.1-3.0 Cm cost with insurance in Pennsylvania?
With commercial insurance in Pennsylvania, Destruction Of Cancer Skin Growth Of Trunk, Arms, Or Legs, 2.1-3.0 Cm costs an estimated $375.19. Without insurance, the estimated cash price is $228.49. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Destruction Of Cancer Skin Growth Of Trunk, Arms, Or Legs, 2.1-3.0 Cm in Pennsylvania?
449 providers in Pennsylvania billed Medicare for Destruction Of Cancer Skin Growth Of Trunk, Arms, Or Legs, 2.1-3.0 Cm in 2023, performing 2.5K total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Destruction Of Cancer Skin Growth Of Trunk, Arms, Or Legs, 2.1-3.0 Cm cheaper in Pennsylvania than the national average?
No — Destruction Of Cancer Skin Growth Of Trunk, Arms, Or Legs, 2.1-3.0 Cm costs 0% above the national average in Pennsylvania. The state average Medicare payment is $129.59 compared to $129.39 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.